GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kingworld Medicines Group Ltd (HKSE:01110) » Definitions » Debt-to-Revenue

Kingworld Medicines Group (HKSE:01110) Debt-to-Revenue : 0.34 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Kingworld Medicines Group Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Kingworld Medicines Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$217 Mil. Kingworld Medicines Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$171 Mil. Kingworld Medicines Group's annualized Revenue for the quarter that ended in Dec. 2023 was HK$1,150 Mil. Kingworld Medicines Group's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.34.


Kingworld Medicines Group Debt-to-Revenue Historical Data

The historical data trend for Kingworld Medicines Group's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kingworld Medicines Group Debt-to-Revenue Chart

Kingworld Medicines Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.24 0.41 0.28 0.30 0.33

Kingworld Medicines Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.29 0.27 0.27 0.34

Competitive Comparison of Kingworld Medicines Group's Debt-to-Revenue

For the Pharmaceutical Retailers subindustry, Kingworld Medicines Group's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kingworld Medicines Group's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Kingworld Medicines Group's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Kingworld Medicines Group's Debt-to-Revenue falls into.



Kingworld Medicines Group Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Kingworld Medicines Group's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(216.6 + 171.064) / 1179.814
=0.33

Kingworld Medicines Group's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(216.6 + 171.064) / 1149.872
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.


Kingworld Medicines Group Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Kingworld Medicines Group's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Kingworld Medicines Group (HKSE:01110) Business Description

Traded in Other Exchanges
N/A
Address
198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016
Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products primarily in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices primarily carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.

Kingworld Medicines Group (HKSE:01110) Headlines

No Headlines